{"id":"https://openalex.org/W4308174530","doi":"https://doi.org/10.1016/j.ygyno.2022.10.016","title":"Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer who are microsatellite instability (MSI)-high or are mismatch repair deficient (dMMR) in the United States","display_name":"Treatment patterns and real-world clinical outcomes in patients with advanced endometrial cancer who are microsatellite instability (MSI)-high or are mismatch repair deficient (dMMR) in the United States","publication_year":2022,"publication_date":"2022-11-04","ids":{"openalex":"https://openalex.org/W4308174530","doi":"https://doi.org/10.1016/j.ygyno.2022.10.016","pmid":"https://pubmed.ncbi.nlm.nih.gov/36344294"},"language":"en","primary_location":{"id":"doi:10.1016/j.ygyno.2022.10.016","doi":"https://doi.org/10.1016/j.ygyno.2022.10.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2022.10.016","pdf_url":"https://www.gynecologiconcology-online.net/article/S0090-8258(22)01893-5/pdf","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.gynecologiconcology-online.net/article/S0090-8258(22)01893-5/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109114547","display_name":"Sneha S. Kelkar","orcid":"https://orcid.org/0009-0005-4262-3040","observed_orcids":["https://orcid.org/0009-0005-4262-3040"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sneha S. Kelkar","raw_affiliation_strings":["OPEN Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OPEN Health, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062529556","display_name":"Vimalanand S. Prabhu","orcid":"https://orcid.org/0000-0003-1358-8846","observed_orcids":["https://orcid.org/0000-0003-1358-8846"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Vimalanand S. Prabhu","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA. Electronic address: vimalanand.prabhu@merck.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA. Electronic address: vimalanand.prabhu@merck.com","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050636650","display_name":"Shelby L. Corman","orcid":"https://orcid.org/0000-0003-4606-2971","observed_orcids":["https://orcid.org/0000-0003-4606-2971"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shelby Corman","raw_affiliation_strings":["OPEN Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OPEN Health, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054416485","display_name":"Shardul Odak","orcid":"https://orcid.org/0000-0002-1443-610X","observed_orcids":["https://orcid.org/0000-0002-1443-610X"]},"institutions":[{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shardul Odak","raw_affiliation_strings":["RTI-Health Solutions, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RTI-Health Solutions, Research Triangle Park, NC, USA","institution_ids":["https://openalex.org/I4210120329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001555365","display_name":"Nifasha Rusibamayila","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nifasha Rusibamayila","raw_affiliation_strings":["OPEN Health, Bethesda, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OPEN Health, Bethesda, MD, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082154728","display_name":"Cynthia P. Macahilig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120329","display_name":"RTI Health Solutions","ror":"https://ror.org/032nh7f71","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I137902535","https://openalex.org/I170897317","https://openalex.org/I180297670","https://openalex.org/I4210120329"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia Macahilig","raw_affiliation_strings":["RTI-Health Solutions, Research Triangle Park, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RTI-Health Solutions, Research Triangle Park, NC, USA","institution_ids":["https://openalex.org/I4210120329"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050009430","display_name":"Robert J. Orlowski","orcid":"https://orcid.org/0000-0002-8037-9932","observed_orcids":["https://orcid.org/0000-0002-8037-9932"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Orlowski","raw_affiliation_strings":["Merck & Co., Inc., Rahway, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Rahway, NJ, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054372225","display_name":"Linda Duska","orcid":"https://orcid.org/0000-0002-8878-4123","observed_orcids":["https://orcid.org/0000-0002-8878-4123"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda Duska","raw_affiliation_strings":["Gynecologic Oncology Division, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gynecologic Oncology Division, Department of Obstetrics and Gynecology, University of Virginia School of Medicine, Charlottesville, VA, USA","institution_ids":["https://openalex.org/I51556381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5062529556"],"corresponding_institution_ids":["https://openalex.org/I1285764155"],"apc_list":{"value":4020,"currency":"USD","value_usd":4020},"apc_paid":{"value":4020,"currency":"USD","value_usd":4020},"fwci":3.226,"has_fulltext":true,"cited_by_count":17,"citation_normalized_percentile":{"value":0.92876896,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"169","issue":null,"first_page":"154","last_page":"163"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10668","display_name":"Endometrial and Cervical Cancer Treatments","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2729","display_name":"Obstetrics and Gynecology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11369","display_name":"Genetic factors in colorectal cancer","score":0.00839999970048666,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-endometrial-cancer","display_name":"advanced endometrial cancer","score":0.9900000095367432},{"id":"https://openalex.org/keywords/microsatellite-instability-high","display_name":"microsatellite instability-high","score":0.968999981880188},{"id":"https://openalex.org/keywords/mismatch-repair-deficiency","display_name":"mismatch repair deficiency","score":0.875},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9399999976158142},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6890000104904175},{"id":"https://openalex.org/keywords/second-line-chemotherapy","display_name":"second-line chemotherapy","score":0.7950000166893005},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9509999752044678},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.8100000023841858},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.7300000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9241842031478882},{"id":"https://openalex.org/C2779767149","wikidata":"https://www.wikidata.org/wiki/Q488212","display_name":"Microsatellite instability","level":5,"score":0.738181471824646},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.712140679359436},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7119606137275696},{"id":"https://openalex.org/C2777088508","wikidata":"https://www.wikidata.org/wiki/Q944777","display_name":"Endometrial cancer","level":3,"score":0.6883922815322876},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.6360504627227783},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5860078930854797},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.485045850276947},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4284055233001709},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.4235893487930298},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.370312362909317},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.28108155727386475},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.0},{"id":"https://openalex.org/C61320498","wikidata":"https://www.wikidata.org/wiki/Q265193","display_name":"Microsatellite","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000068258","descriptor_name":"Bevacizumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016889","descriptor_name":"Endometrial Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053842","descriptor_name":"Microsatellite Instability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053843","descriptor_name":"DNA Mismatch Repair","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ygyno.2022.10.016","doi":"https://doi.org/10.1016/j.ygyno.2022.10.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2022.10.016","pdf_url":"https://www.gynecologiconcology-online.net/article/S0090-8258(22)01893-5/pdf","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},{"id":"pmid:36344294","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36344294","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.ygyno.2022.10.016","doi":"https://doi.org/10.1016/j.ygyno.2022.10.016","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ygyno.2022.10.016","pdf_url":"https://www.gynecologiconcology-online.net/article/S0090-8258(22)01893-5/pdf","source":{"id":"https://openalex.org/S2574783","display_name":"Gynecologic Oncology","issn_l":"0090-8258","issn":["0090-8258","1095-6859"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gynecologic Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307776","display_name":"Merck","ror":"https://ror.org/02891sr49"},{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4308174530.pdf","grobid_xml":"https://content.openalex.org/works/W4308174530.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W209156477","https://openalex.org/W1981989535","https://openalex.org/W1992938169","https://openalex.org/W1999130958","https://openalex.org/W2134159332","https://openalex.org/W2140382400","https://openalex.org/W2153973908","https://openalex.org/W2612419201","https://openalex.org/W2947159010","https://openalex.org/W2954523357","https://openalex.org/W2970410478","https://openalex.org/W3009897923","https://openalex.org/W3167167915","https://openalex.org/W3167637623","https://openalex.org/W4206041598","https://openalex.org/W4243752273","https://openalex.org/W4283023055"],"related_works":["https://openalex.org/W3205729255","https://openalex.org/W4283023055","https://openalex.org/W2140979181","https://openalex.org/W3205412400","https://openalex.org/W4388042400","https://openalex.org/W7221333660","https://openalex.org/W3173074092","https://openalex.org/W4210697981","https://openalex.org/W6939987234","https://openalex.org/W4393006033"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Microsatellite":[1],"instability-high":[2],"(MSI-H)":[3],"and":[4,31,74,77,89,92,107,140,149,157,172,178,202,210,228],"deficient":[5],"DNA":[6],"mismatch":[7],"repair":[8],"(dMMR)":[9],"status":[10],"have":[11],"emerged":[12],"as":[13],"actionable":[14],"biomarkers":[15],"for":[16,81,235,244],"advanced":[17],"endometrial":[18],"cancer":[19],"(aEC).":[20],"The":[21],"objective":[22],"of":[23,63,118,142,233],"this":[24],"study":[25,62],"was":[26,56,134],"to":[27,101],"assess":[28],"clinical":[29,88,93,226],"outcomes":[30,94],"treatment":[32,90],"patterns":[33],"among":[34,164,185,198],"MSI-H/dMMR":[35,66,236],"aEC":[36,67,138,237],"patients":[37,64,121,143,166,187,192,238],"who":[38,68,122,167,188,240],"had":[39,69],"disease":[40,70],"progression":[41,71],"following":[42],"prior":[43],"systemic":[44],"therapy":[45],"(FPST)":[46],"in":[47,247],"the":[48,231],"US.":[49],"METHODS:":[50],"Endometrial":[51],"Cancer":[52],"Health":[53],"Outcomes":[54],"(ECHO)":[55],"a":[57],"retrospective,":[58],"medical":[59],"chart":[60],"review":[61],"with":[65],"between":[72],"07/01/2016":[73],"12/31/2018":[75],"FPST":[76,239],"were":[78,95,99,130,144,151,204],"not":[79,179,242],"candidates":[80,243],"curative":[82,245],"surgery.":[83],"Data":[84],"on":[85],"patient":[86],"demographics,":[87],"characteristics,":[91],"collected.":[96],"Kaplan-Meier":[97],"analyses":[98],"performed":[100],"estimate":[102],"real-world":[103,248],"progression-free":[104],"survival":[105,109],"(rwPFS)":[106],"overall":[108],"(OS),":[110],"stratified":[111],"by":[112],"drug":[113],"class.":[114],"RESULTS:":[115],"A":[116],"total":[117],"124":[119],"eligible":[120],"initiated":[123],"second-line":[124],"chemotherapy":[125,169],"\u00b1":[126,170],"bevacizumab":[127],"or":[128],"immunotherapy":[129],"included.":[131],"Mean":[132],"age":[133],"61.4":[135],"years":[136],"at":[137],"diagnosis":[139],"86.3%":[141],"stage":[145],"IIIB-IV.":[146],"Median":[147],"rwPFS":[148,201],"OS":[150,203],"4.0":[152],"months":[153,159,174,206,212],"(95%":[154,160,175,181,207,213],"CI:":[155,161,176,182,208,214],"2.0-9.0)":[156],"7.0":[158],"5.0-18.0),":[162],"respectively,":[163,184],"21":[165],"received":[168,189,196],"bevacizumab,":[171],"29.0":[173,205],"18.0-NE)":[177,209],"reached":[180],"30.0-NA),":[183,215],"103":[186],"immunotherapy.":[190],"Most":[191],"(n":[193],"=":[194],"92)":[195],"pembrolizumab;":[197],"these":[199],"patients,":[200],"30":[211],"respectively.":[216],"CONCLUSIONS:":[217],"Real-world":[218],"evidence":[219],"suggests":[220],"that":[221],"pembrolizumab":[222],"monotherapy":[223],"provides":[224],"considerable":[225],"benefits":[227],"has":[229],"become":[230],"standard":[232],"care":[234],"are":[241],"surgery":[246],"settings.":[249]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-11-08T00:00:00"}